INCELL Corporation specializes in proprietary platform technology that stimulates mucosal immunity for the development of oral vaccines. The company provides specialty reagents and media that transport, grow and cryopreserve human and other mammalian cells and tissues. It offers primary cultures, stem cells and cell lines for research and preclinical testing applications. INCELL Corporation s omega-3 fatty acid supplements are designed to improve cancer treatment outcomes. The company s capabilities include cell metabolism and transport, histology, culture production and maintenance, proliferation, toxicity assays, immunohistochemistry and microscopy. It also performs research and development operations. INCELL Corporation is based in San Antonio.